DNA checkpoint gene mutation as a biomarker of immune checkpoint inhibitor in advanced biliary tract cancer

被引：0
|
作者：
Shin, Ji Eun
Kim, Seung Tae
Choi, Dae-Ho
Lee, Junho
Hyeon, Jiyeon
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7624
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7624
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer
    Shin, Ji Eun
    Kim, Seung Tae
    [J]. ANTICANCER RESEARCH, 2024, 44 (05) : 2103 - 2108
  • [2] The Efficacy of Immune Checkpoint Inhibitors in Advanced Biliary Tract Cancer with KRAS Mutation
    Jeong, Sun Young
    Jang, Jaeyeon
    Jeon, Youngkyung
    Jung, Ye Ji
    Choi, Daeho
    Hong, Joohyun
    Kim, Seung Tae
    Hong, Jung Yong
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer
    Taghizadeh, Hossein
    Prager, Gerald W.
    [J]. CURRENT CANCER DRUG TARGETS, 2022, 22 (08) : 639 - 650
  • [4] Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)
    Jakubowski, Christopher D.
    Azad, Nilofer S.
    [J]. CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
  • [5] The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation
    Jeong, Sun Young
    Hong, Jung Yong
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Jang, Jae Yeon
    Jeon, Youngkyung
    Kim, Seung Tae
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [6] Immune checkpoint inhibitor for patients with advanced biliary tract cancer: A cost-effectiveness analysis
    Zhu, Youwen
    Liu, Kun
    Zhu, Hong
    [J]. LIVER INTERNATIONAL, 2023, 43 (10) : 2292 - 2301
  • [7] The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.
    Jeong, Sun Young
    Kim, Seung Tae
    Jang, Jae Yeon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 598 - 598
  • [8] Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study
    Shieh, Kevin R.
    Huang, Anna
    Xu, Yiqing
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [9] Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer
    Liddell, Savannah S.
    Chakrabarti, Sakti
    Wintheiser, Grant A.
    Zemla, Tyler J.
    Shi, Qian
    Tella, Sri Harsha
    Jin, Zhaohui
    Wookey, Vanessa B.
    Hassan, Hind
    Tran, Nguyen H.
    Borad, Mitesh J.
    Mahipal, Amit
    [J]. JCO PRECISION ONCOLOGY, 2022, 6
  • [10] DNA damage and repair gene panel as a biomarker of immune checkpoint inhibitor response.
    Chen, Ming Huang
    Pan, Yi-Ru
    Wu, Chiao-En
    Yeh, Yi Chen
    Hung, Yi-Ping
    Chao, Yee
    Wang, Yu-Chao
    Lin, Chien-Hsing
    Hsieh, Jason Chia-Hsun
    Yeh, Chun-Nan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345